Publications by authors named "Phil B Alper"

Claim this Profile
D
Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway.
Phil B Alper, Jonathan Deane, Claudia Betschart, David Buffet, Géraldine Collignon Zipfel

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
Thomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, Marjorie Bourrel, Eric Vangrevelinghe, Phil B Alper

J Med Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoinduced Rearrangement of Dienones and Santonin Rerouted by Amines.
Zhipeng Zhang, Maxim Ratnikov, Glen Spraggon, Phil B Alper

Angew Chem Int Ed Engl· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
David C Tully, Paul V Rucker, Donatella Chianelli, Jennifer Williams, Agnès Vidal, Phil B Alper

J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor.
Phil B Alper, Thomas H Marsilje, Daniel Mutnick, Wenshuo Lu, Arnab Chatterjee

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffold.
Thomas H Marsilje, Phil B Alper, Wenshuo Lu, Daniel Mutnick, Pierre-Yves Michellys

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.
David C Tully, Hong Liu, Arnab K Chatterjee, Phil B Alper, Robert Epple

Bioorg Med Chem Lett· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
David C Tully, Hong Liu, Arnab K Chatterjee, Phil B Alper, Jennifer A Williams

Bioorg Med Chem Lett· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3.
David C Tully, Hong Liu, Phil B Alper, Arnab K Chatterjee, Robert Epple

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
Hong Liu, David C Tully, Robert Epple, Badry Bursulaya, Jun Li, Phil B Alper

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical synthesis and elaboration of methyl 7-chloroindole-4-carboxylate.
Phil B Alper, KhanhLinh T Nguyen

J Org Chem· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis